Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
7419 Nojima
- 2326
- +6+0.26%
20min DelayMarket Closed Dec 16 15:30 JST
238.60BMarket Cap11.57P/E (Static)
2338High2301Low133.10KVolume2306Open2320Pre Close308.71MTurnover245952wk High0.25%Turnover Ratio102.58MShares147852wk Low250.57EPS TTM125.27BFloat Cap2459Historical High11.57P/E (Static)53.86MShs Float46Historical Low201.11EPS LYR1.60%Amplitude38.00Dividend TTM1.19P/B100Lot Size1.63%Div YieldTTM
Nojima Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.11%189.06B | 21.58%761.3B | -2.04%200.65B | 35.96%202.58B | 36.28%186.36B | 26.63%171.71B | 10.83%626.18B | 35.51%204.84B | 4.03%149.01B | 3.50%136.74B |
| Cost of revenue | 12.20%133.63B | 21.86%541.75B | -2.32%143.82B | 37.85%147.88B | 37.49%130.94B | 25.61%119.1B | 11.60%444.56B | 38.39%147.23B | 5.22%107.28B | 2.01%95.24B |
| Gross profit | 5.38%55.44B | 20.89%219.55B | -1.35%56.83B | 31.08%54.7B | 33.53%55.41B | 29.00%52.61B | 8.99%181.62B | 28.67%57.61B | 1.12%41.73B | 7.07%41.5B |
| Operating expense | 0.67%47.66B | 27.66%188.99B | -2.14%47.55B | 35.67%46.93B | 46.11%47.17B | 45.31%47.34B | 10.91%148.04B | 46.24%48.59B | 3.30%34.59B | -1.24%32.28B |
| Staff costs | ---- | 42.06%72.47B | ---- | ---- | ---- | ---- | 18.04%51.01B | ---- | ---- | ---- |
| Selling and administrative expenses | ---- | 2.72%22.35B | ---- | ---- | ---- | ---- | 0.64%21.76B | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 2.72%22.35B | ---- | ---- | ---- | ---- | 0.64%21.76B | ---- | ---- | ---- |
| Depreciation and amortization | ---- | 25.77%20.96B | ---- | ---- | ---- | ---- | 8.01%16.67B | ---- | ---- | ---- |
| -Depreciation | ---- | 16.12%15.64B | ---- | ---- | ---- | ---- | 6.48%13.47B | ---- | ---- | ---- |
| -Amortization | ---- | 66.44%5.32B | ---- | ---- | ---- | ---- | 14.96%3.2B | ---- | ---- | ---- |
| Rent and land expenses | ---- | 16.21%24.67B | ---- | ---- | ---- | ---- | 18.51%21.23B | ---- | ---- | ---- |
| Other operating expenses | ---- | 29.86%48.53B | ---- | ---- | ---- | ---- | 5.89%37.37B | ---- | ---- | ---- |
| Operating profit | 47.67%7.78B | -8.96%30.57B | 2.92%9.28B | 8.87%7.77B | -10.52%8.25B | -35.78%5.27B | 1.22%33.57B | -21.91%9.02B | -8.26%7.14B | 51.77%9.22B |
| Net non-operating interest income (expenses) | -54.76%-195M | -31.68%-532M | -10.62%-125M | -56.18%-139M | -44.90%-142M | -21.15%-126M | 34.09%-404M | 20.42%-113M | 41.45%-89M | 39.51%-98M |
| Non-operating interest income | -15.87%53M | 31.90%215M | 1.69%60M | -10.00%36M | 43.59%56M | 152.00%63M | 340.54%163M | 436.36%59M | 263.64%40M | 387.50%39M |
| Non-operating interest expense | 31.22%248M | 31.75%747M | 7.56%185M | 35.66%175M | 44.53%198M | 46.51%189M | -12.77%567M | 12.42%172M | -20.86%129M | -19.41%137M |
| Net investment income | 145M | 81.21%-28M | -112.50%-17M | -147.62%-10M | -152.10%-149M | -900.00%-8M | 167.74%21M | -1,700.00%-112M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -64.61%63M | 0 | 106.38%178M | 100.66%19M | ||||||
| Income from associates and other participating interests | -2,300.00%-24M | 5.88%90M | 21.05%23M | 25.00%25M | -21.82%43M | 88.89%-1M | -23.42%85M | 18.75%19M | -53.49%20M | 14.58%55M |
| Special income (charges) | -442.86%-48M | 59.70%-54M | 50.51%-145M | -663.89%-275M | 2,414.29%352M | -92.27%14M | -102.39%-134M | -104.91%-293M | 80.85%-36M | 107.78%14M |
| Less:Restructuring and mergern&acquisition | --57M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 56.00%-11M | -28.04%-580M | -295.00%-79M | 370.00%54M | -158.54%-530M | 87.98%-25M | 92.18%-453M | 99.67%-20M | -106.12%-20M | -66.67%-205M |
| Less:Write off | -81.82%2M | 8.01%634M | -28.43%224M | 321.43%236M | -14.66%163M | -59.26%11M | 56.53%587M | 1,741.18%313M | 16.67%56M | -36.96%191M |
| Other non-operating income (expenses) | 36.36%930M | -6.14%2.78B | 425.64%615M | -12.88%778M | -9.46%708M | -41.86%682M | 0.82%2.97B | -86.51%117M | 3.96%893M | 130.00%782M |
| Income before tax | 47.09%8.59B | -8.94%32.88B | 9.96%9.62B | 1.33%8.22B | -6.64%9.2B | -37.85%5.84B | -6.70%36.11B | -43.05%8.75B | -2.57%8.11B | 58.93%9.86B |
| Income tax | 21.70%2.97B | -0.34%12.64B | 15.49%3.75B | 4.62%3.15B | 3.25%3.3B | -24.42%2.44B | -0.62%12.68B | -27.68%3.25B | -0.53%3.01B | 29.68%3.2B |
| Net income | 65.36%5.61B | -13.60%20.24B | 6.68%5.87B | -0.63%5.07B | -11.36%5.9B | -44.90%3.4B | -9.69%23.43B | -49.39%5.51B | -3.71%5.11B | 78.16%6.66B |
| Net income continuous operations | 65.34%5.62B | -13.60%20.24B | 6.70%5.87B | -0.61%5.08B | -11.39%5.9B | -44.89%3.4B | -9.69%23.43B | -49.40%5.5B | -3.73%5.11B | 78.23%6.66B |
| Noncontrolling interests | -62.00%19M | 129.82%262M | 165.85%109M | 194.74%56M | 113.64%47M | 56.25%50M | 42.50%114M | -48.75%41M | 19M | 22M |
| Net income attributable to the company | 67.26%5.6B | -14.31%19.98B | 5.49%5.76B | -1.38%5.02B | -11.77%5.85B | -45.43%3.35B | -9.85%23.32B | -49.39%5.46B | -4.07%5.09B | 77.57%6.63B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 67.26%5.6B | -14.31%19.98B | 5.49%5.76B | -1.38%5.02B | -11.77%5.85B | -45.43%3.35B | -9.85%23.32B | -49.39%5.46B | -4.07%5.09B | 77.57%6.63B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 68.22%57.33 | -14.72%203.67 | 5.37%58.85 | -1.88%51.21 | -11.85%59.53 | -45.70%34.08 | -8.65%238.83 | -49.02%55.85 | -2.50%52.19 | 80.18%67.532 |
| Diluted earnings per share | 65.69%55.77 | -14.75%201.11 | 4.82%57.88 | -2.16%50.63 | -12.32%58.94 | -45.45%33.66 | -8.05%235.9 | -48.61%55.22 | -2.14%51.75 | 82.27%67.22 |
| Dividend per share | 0 | 17.86%33 | 20.00%18 | 0 | 15.38%15 | 0 | 12.00%28 | 15.38%15 | 0 | 8.33%13 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |